Chemistry professor at Columbia University with research background in synthetic and medicinal chemistry, molecular imaging, and neuropharmacology. His work has included research on C-H bond functionalization methods, fluorescent probes for synaptic imaging, and the pharmacology of various natural alkaloids.
Intro paths
YC
Dalibor went through Y Combinator (Summer 2020) — any YC alum in your network can reach them through the YC community.
→
In turn, Dalibor can intro founders to Gilgamesh Pharmaceuticals's investors below.
Gilgamesh Pharmaceuticals's investors · 2
Co-founders
JONATHAN SPORN· FounderAndrew Kruegel· FounderJonathan Sporn· Founder & CEO